Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by eSnowdenon Mar 04, 2014 5:57pm

276 Views

Post# 22280132

RE:RE:Company valuation is pathetic.

US-based Elite Pharma (ELTP) has similar financials to Medicure, primarily into generics, and has nothing near the potential of a transdermal Aggrastat in their portfolio, yet has a market cap of over $400million...

If Medicure became US-based (of which they have offices in New Jersey), and promoted their company a bit more, you could easily see a valuation between $50-$100million on a US exchange.

Reasons for the current share price? By solely relying on Canadian investors--the real money is in the US. There is a cross-listed ticker (MCUJF)--of which I own shares. Yet, my brokerage no longer allows purchases of foreign stocks, only allows the sale of existing shares.

Bullboard Posts

Stockhouse DealRoom opens new Australian opportunities